Generics The Russian Ministry of Health plans to initiate talks with US biotech major Gilead Sciences on beginning production of generic versions of its sofosbuvir, marketed as Sovaldi, which is a drug for the treatment of hepatitis C, that was included in the list of vital and essential medicines in Russia for 2019, reports The Pharma Letter’s local correspondent. 17 September 2018